Tags

Type your tag names separated by a space and hit enter

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).
Nutrients 2013; 5(10):4093-114N

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD.

Authors+Show Affiliations

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. beth.conlon@phd.einstein.yu.edu.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

24152749

Citation

Conlon, Beth A., et al. "Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)." Nutrients, vol. 5, no. 10, 2013, pp. 4093-114.
Conlon BA, Beasley JM, Aebersold K, et al. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients. 2013;5(10):4093-114.
Conlon, B. A., Beasley, J. M., Aebersold, K., Jhangiani, S. S., & Wylie-Rosett, J. (2013). Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients, 5(10), pp. 4093-114. doi:10.3390/nu5104093.
Conlon BA, et al. Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD). Nutrients. 2013 Oct 11;5(10):4093-114. PubMed PMID: 24152749.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). AU - Conlon,Beth A, AU - Beasley,Jeannette M, AU - Aebersold,Karin, AU - Jhangiani,Sunil S, AU - Wylie-Rosett,Judith, Y1 - 2013/10/11/ PY - 2013/05/18/received PY - 2013/08/14/revised PY - 2013/09/19/accepted PY - 2013/10/25/entrez PY - 2013/10/25/pubmed PY - 2014/5/9/medline SP - 4093 EP - 114 JF - Nutrients JO - Nutrients VL - 5 IS - 10 N2 - Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD. SN - 2072-6643 UR - https://www.unboundmedicine.com/medline/citation/24152749/Nutritional_management_of_insulin_resistance_in_nonalcoholic_fatty_liver_disease__NAFLD__ L2 - http://www.mdpi.com/resolver?pii=nu5104093 DB - PRIME DP - Unbound Medicine ER -